Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PCSA

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCSA
DateTimeSourceHeadlineSymbolCompany
19/09/202406:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/09/202406:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/09/202406:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/09/202422:00GlobeNewswire Inc.Processa Pharmaceuticals to Participate in Investor and Industry Conferences During SeptemberNASDAQ:PCSAProcessa Pharmaceuticals Inc
28/08/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
28/08/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Provides Product Pipeline and Financial UpdateNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/08/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-IriNASDAQ:PCSAProcessa Pharmaceuticals Inc
14/08/202406:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
03/08/202407:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/08/202407:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/08/202407:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/08/202407:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/07/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/07/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
23/07/202407:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PCSAProcessa Pharmaceuticals Inc
17/07/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
17/07/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial OfficerNASDAQ:PCSAProcessa Pharmaceuticals Inc
12/06/202404:19Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/06/202422:20GlobeNewswire Inc.Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
29/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PCSAProcessa Pharmaceuticals Inc
29/05/202406:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
22/05/202406:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/05/202406:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PCSAProcessa Pharmaceuticals Inc
11/05/202406:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
06/05/202422:00GlobeNewswire Inc.Processa Pharmaceuticals to Participate in the EF Hutton Annual Global ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/04/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical ResearchNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/04/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
28/03/202423:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
25/03/202423:15GlobeNewswire Inc.Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/02/202409:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA

Your Recent History

Delayed Upgrade Clock